+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Interoperability Solutions Market by Level, Deployment and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 210 Pages
  • October 2021
  • Region: Global
  • Allied Market Research
  • ID: 5521569
Description Jump to:
The healthcare interoperability solutions market was valued at $5,320.0 million in 2020, and is expected to reach $21,544.6 million by 2030, registering a CAGR of 14.9% from 2021 to 2030. Interoperability solutions have the ability to access different information systems, devices and applications (systems) to access, exchange, integrate and cooperatively use data in a coordinated manner, within and across organizational, regional and national boundaries, to provide timely and seamless portability of information and optimize the health of individuals and populations globally.



The major factors driving the healthcare interoperability solutions market are adoption of cloud technology related to healthcare services. It is difficult to share the bulk amount of data via offline mode. Hence, adoption of healthcare interoperability solutions in the healthcare industry becomes necessary because it allows easy sharing and storage. In addition, implementation of various healthcare reforms by the governments has raised the demand for healthcare interoperability solutions in the market. However, data security issues regarding the patient data safety & security acts as restrain to the market. Cyber-attacks and hacking of sensitive data through these interoperability solutions hampers the growth of the market. On the contrary, increasing investment in the Asia-Pacific region offers huge market potential. Digitalization of healthcare industry in developing nations of Asia-Pacific and LAMEA is at its nascent stage and the demand for healthcare interoperability solutions is expected to increase during the forecast period, owing to increase in chronic disorders, improvements in healthcare infrastructure, and surge in demand for better healthcare services such as healthcare interoperability solutions during the forecast period.

The healthcare interoperability solutions market is segmented on the basis of level, deployment, end-user and region. By level, the market is segregated into foundational, structural and semantic. On the basis of deployment, the market is divided into cloud-based and on-premise. On the basis of end-user, the market is divided into healthcare providers and healthcare payers. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Competition analysis

The major players profiled in the healthcare interoperability solutions market include Allscripts Healthcare, LLC, Cerner Corporation, Epic Systems Corporation, Infor, InterSystems Corporation, Jitterbit, Koninklijke Philips N.V., NextGen Healthcare, Inc., Orion Health and ViSolve Inc. Major companies in the market have adopted product launch, business expansion and acquisition as their key developmental strategies to offer better products and services to customers in the healthcare interoperability solutions market.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an extensive analysis of the current trends, future estimations, and dynamics of the healthcare interoperability solutions market.
  • In-depth healthcare interoperability solutions market analysis is conducted by estimations for the key segments between 2021 and 2030.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive analysis of four major regions is provided to determine the prevailing opportunities.
  • The market forecast analysis from 2021 to 2030 is included in the report.
  • The key market players operating in the market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market industry.

KEY MARKET SEGMENTS


By Level

  • Foundational
  • Structural
  • Semantic

By Deployment

  • Cloud-based
  • On-premise

By End-User

  • Healthcare Providers
  • Healthcare Payers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

KEY PLAYERS

  • Allscripts Healthcare, LLC
  • Cerner Corporation
  • Epic Systems Corporation
  • Infor
  • InterSystems Corporation
  • Jitterbit
  • Koninklijke Philips N.V.
  • NextGen Healthcare, Inc.
  • Orion Health
  • ViSolve Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Research methodology
1.2.1. Primary research
1.2.2. Secondary research
1.2.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top impacting factors
3.2.3. Market player positioning
3.3. Key forces shaping healthcare interoperability solutions industry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Adoption of Cloud technology related to healthcare services
3.4.1.2. Implementation of various healthcare reforms such as Patient Protection and Affordable Care Act (PPACA)
3.4.2. Restraint
3.4.2.1. Increase in concerns regarding the patient data safety & security
3.4.3. Opportunity
3.4.3.1. Increasing investment in the Asia-Pacific region offers huge market potential
3.5. COVID-19 impact analysis
CHAPTER 4: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL
4.1. Market overview
4.1.1. Market size and forecast, by level
4.2. Foundational
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Structural
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Semantic
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT
5.1. Market overview
5.1.1. Market size and forecast, by deployment
5.2. Cloud-based
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. On-premise
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER
6.1. Market overview
6.1.1. Market size and forecast, by end-user
6.2. Healthcare providers
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Market size and forecast, for healthcare providers, by deployment
6.3. Healthcare payers
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
CHAPTER 7: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
7.1. Market overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by level
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end-user
7.2.5. Market size and forecast, for healthcare providers, by deployment
7.2.6. Market size and forecast, by country
7.2.6.1. U.S.
7.2.6.1.1. Market size and forecast, by level
7.2.6.1.2. Market size and forecast, by deployment
7.2.6.1.3. Market size and forecast, by end-user
7.2.6.2. Canada
7.2.6.2.1. Market size and forecast, by level
7.2.6.2.2. Market size and forecast, by deployment
7.2.6.2.3. Market size and forecast, by end-user
7.2.6.3. Mexico
7.2.6.3.1. Market size and forecast, by level
7.2.6.3.2. Market size and forecast, by deployment
7.2.6.3.3. Market size and forecast, by end-user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by level
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end-user
7.3.5. Market size and forecast, for healthcare providers, by deployment
7.3.6. Market size and forecast, by country
7.3.6.1. Germany
7.3.6.1.1. Market size and forecast, by level
7.3.6.1.2. Market size and forecast, by deployment
7.3.6.1.3. Market size and forecast, by end-user
7.3.6.2. France
7.3.6.2.1. Market size and forecast, by level
7.3.6.2.2. Market size and forecast, by deployment
7.3.6.2.3. Market size and forecast, by end-user
7.3.6.3. UK
7.3.6.3.1. Market size and forecast, by level
7.3.6.3.2. Market size and forecast, by deployment
7.3.6.3.3. Market size and forecast, by end-user
7.3.6.4. Italy
7.3.6.4.1. Market size and forecast, by level
7.3.6.4.2. Market size and forecast, by deployment
7.3.6.4.3. Market size and forecast, by end-user
7.3.6.5. Rest of Europe
7.3.6.5.1. Market size and forecast, by level
7.3.6.5.2. Market size and forecast, by deployment
7.3.6.5.3. Market size and forecast, by end-user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by level
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end-user
7.4.5. Market size and forecast, for healthcare providers, by deployment
7.4.6. Market size and forecast, by country
7.4.6.1. China
7.4.6.1.1. Market size and forecast, by level
7.4.6.1.2. Market size and forecast, by deployment
7.4.6.1.3. Market size and forecast, by end-user
7.4.6.2. Japan
7.4.6.2.1. Market size and forecast, by level
7.4.6.2.2. Market size and forecast, by deployment
7.4.6.2.3. Market size and forecast, by end-user
7.4.6.3. South Korea
7.4.6.3.1. Market size and forecast, by level
7.4.6.3.2. Market size and forecast, by deployment
7.4.6.3.3. Market size and forecast, by end-user
7.4.6.4. India
7.4.6.4.1. Market size and forecast, by level
7.4.6.4.2. Market size and forecast, by deployment
7.4.6.4.3. Market size and forecast, by end-user
7.4.6.5. Rest of Asia-Pacific
7.4.6.5.1. Market size and forecast, by level
7.4.6.5.2. Market size and forecast, by deployment
7.4.6.5.3. Market size and forecast, by end-user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by level
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end-user
7.5.5. Market size and forecast, for healthcare providers, by deployment
7.5.6. Market size and forecast, by country
7.5.6.1. Latin America
7.5.6.1.1. Market size and forecast, by level
7.5.6.1.2. Market size and forecast, by deployment
7.5.6.1.3. Market size and forecast, by end-user
7.5.6.2. Middle East
7.5.6.2.1. Market size and forecast, by level
7.5.6.2.2. Market size and forecast, by deployment
7.5.6.2.3. Market size and forecast, by end-user
7.5.6.3. Africa
7.5.6.3.1. Market size and forecast, by level
7.5.6.3.2. Market size and forecast, by deployment
7.5.6.3.3. Market size and forecast, by end-user
CHAPTER 8: COMPANY PROFILES
8.1. Allscripts Healthcare, LLC
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. R&D Expenditure
8.1.7. Business performance
8.2. Cerner Corporation
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. R&D Expenditure
8.2.7. Business performance
8.3. Epic Systems Corporation
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Product portfolio
8.4. Infor
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Product portfolio
8.5. InterSystems Corporation
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Product portfolio
8.6. Jitterbit
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Product portfolio
8.7. Koninklijke Philips N.V.
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. R&D Expenditure
8.7.7. Business performance
8.8. NextGen Healthcare, Inc.
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business categories
8.8.5. Product portfolio
8.8.6. R&D Expenditure
8.8.7. Business performance
8.9. Orion Health
8.9.1. Company overview
8.9.2. Key executive
8.9.3. Company snapshot
8.9.4. Product portfolio
8.10. ViSolve Inc.
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Product portfolio
List of Tables
TABLE 01. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY LEVEL, 2020-2030 ($MILLION)
TABLE 02. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR FOUNDATIONAL, BY REGION, 2020-2030 ($MILLION)
TABLE 03. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR STRUCTURAL, BY REGION, 2020-2030 ($MILLION)
TABLE 04. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR SEMANTIC, BY REGION, 2020-2030 ($MILLION)
TABLE 05. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 06. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR CLOUD-BASED, BY REGION, 2020-2030 ($MILLION)
TABLE 07. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR ON-PREMISE, BY REGION, 2020-2030 ($MILLION)
TABLE 08. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, BY END-USER, 2020-2030 ($MILLION)
TABLE 09. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 11. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PAYERS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 14. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18. U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 19. U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 20. U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 21. CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 22. CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 23. CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 24. MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 25. MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 26. MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 27. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 28. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 29. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 30. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 31. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32. GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 33. GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 34. GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 35. FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 36. FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 37. FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 38. UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 39. UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 40. UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 41. ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 42. ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 43. ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 44. REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 45. REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 46. REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 47. ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 48. ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 49. ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 50. ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 52. CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 53. CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 54. CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 55. JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 56. JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 57. JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 58. SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 59. SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 60. SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 61. INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 62. INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 63. INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 67. LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 68. LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 69. LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 70. LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 71. LAMEA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72. LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 73. LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 74. LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 75. MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 76. MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 77. MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 78. AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030 ($MILLION)
TABLE 79. AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030 ($MILLION)
TABLE 80. AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030 ($MILLION)
TABLE 81. ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVES
TABLE 82. ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
TABLE 83. ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
TABLE 84. ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
TABLE 85. CERNER CORPORATION: KEY EXECUTIVES
TABLE 86. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 87. CERNER CORPORATION: OPERATING SEGMENTS
TABLE 88. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 89. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 90. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 91. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 92. INFOR: KEY EXECUTIVES
TABLE 93. INFOR: COMPANY SNAPSHOT
TABLE 94. INFOR: PRODUCT PORTFOLIO
TABLE 95. INTERSYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 96. INTERSYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 97. INTERSYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 98. JITTERBIT: KEY EXECUTIVES
TABLE 99. JITTERBIT: COMPANY SNAPSHOT
TABLE 100. JITTERBIT: PRODUCT PORTFOLIO
TABLE 101. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 102. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 103. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 104. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 105. NEXTGEN HEALTHCARE, INC.: KEY EXECUTIVES
TABLE 106. NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT
TABLE 107. NEXTGEN HEALTHCARE, INC.: BUSINESS CATEGORIES
TABLE 108. NEXTGEN HEALTHCARE, INC.: PRODUCT PORTFOLIO
TABLE 109. ORION HEALTH: KEY EXECUTIVE
TABLE 110. ORION HEALTH: COMPANY SNAPSHOT
TABLE 111. ORION HEALTH: PRODUCT PORTFOLIO
TABLE 112. VISOLVE INC.: KEY EXECUTIVES
TABLE 113. VISOLVE INC.: COMPANY SNAPSHOT
TABLE 114. VISOLVE INC.: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT, 2020-2030
FIGURE 03. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT, BY COUNTRY, 2020-2030
FIGURE 04. GLOBAL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY PLAYERS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP IMPACTING FACTORS
FIGURE 07. MARKET PLAYER POSITIONING
FIGURE 08. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 11. MODERATE BARGAINING POWER OF BUYERS
FIGURE 12. MODERATE-TO-HIGH INTENSITY OF RIVALRY
FIGURE 13. MARKET DYNAMICS
FIGURE 14. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY LEVEL, 2020-2030
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT, 2020-2030
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR CLOUD-BASED, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR ON-PREMISE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER, 2020-2030
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2030
FIGURE 25. U.S. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 26. CANADA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 27. MEXICO HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 28. GERMANY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 29. FRANCE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 30. UK HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 31. ITALY HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 32. REST OF EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 33. CHINA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 34. JAPAN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 35. SOUTH KOREA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 36. INDIA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 37. REST OF ASIA-PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 38. LATIN AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 39. MIDDLE EAST HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 40. AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 41. ALLSCRIPTS HEALTHCARE, LLC: R&D EXPENDITURE, 2018-2020 ($MILLIONS)
FIGURE 42. ALLSCRIPTS HEALTHCARE, LLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 43. ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 44. ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45. CERNER CORPORATION: R&D EXPENDITURE, 2018-2020 ($MILLIONS)
FIGURE 46. CERNER CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 47. CERNER CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48. KONINKLIJKE PHILIPS N.V.: R&D EXPENDITURE, 2018-2020 ($MILLIONS)
FIGURE 49. KONINKLIJKE PHILIPS N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 50. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52. NEXTGEN HEALTHCARE, INC.: R&D EXPENDITURE, 2018-2020 ($MILLIONS)
FIGURE 53. NEXTGEN HEALTHCARE, INC.: NET SALES, 2018-2020 ($MILLION)

Companies Mentioned

  • Allscripts Healthcare LLC
  • Cerner Corporation
  • Epic Systems Corporation
  • Infor
  • InterSystems Corporation
  • Jitterbit
  • Koninklijke Philips N.V.
  • NextGen Healthcare Inc.
  • Orion Health and ViSolve Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages210
PublishedOctober 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 5320 million
Forecasted Market Value ( USD ) by 2030 $ 21544.6 million
Compound Annual Growth Rate15.0%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Healthcare Interoperability Solutions Market by Component, Level, Deployment, End-User - Global Forecast 2025-2030 - Product Image

Healthcare Interoperability Solutions Market by Component, Level, Deployment, End-User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Healthcare Interoperability Solutions - Global Strategic Business Report - Product Image

Healthcare Interoperability Solutions - Global Strategic Business Report

  • Report
  • 648 Pages
  • Global
From
Healthcare Interoperability Solutions Market Size, Share & Trends Analysis Report By Type (Solutions, Services), By Level (Foundational), By Application, By Deployment Method, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Healthcare Interoperability Solutions Market Size, Share & Trends Analysis Report By Type (Solutions, Services), By Level (Foundational), By Application, By Deployment Method, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Healthcare Interoperability Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Healthcare Interoperability Solutions - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Healthcare Interoperability Solutions Market - Forecasts from 2023 to 2028 - Product Image

Healthcare Interoperability Solutions Market - Forecasts from 2023 to 2028

  • Report
  • 141 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.